Filter
1301
Text search:
drug
regulation
Featured
85
374
Language
Document type
756
233
158
60
57
11
10
9
3
3
1
Countries / Regions
65
53
44
44
36
36
34
31
28
22
21
21
21
20
20
19
18
18
17
17
15
15
14
14
14
14
14
12
11
11
8
8
8
8
7
7
6
6
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
567
80
78
37
23
23
9
Toolboxes
152
126
81
81
70
46
34
32
22
18
17
15
14
11
11
8
7
6
5
3
3
1
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and
...
The Blueprint is intended to guide programming, resource allocation, and commitments to achieve the national objective of a contraceptive prevalence rate (CPR) of 36 percent by 2018.
A series of tools and templates have been developed by WHO, FAO and OIE to accompany the manual for developing national action plans on antimicrobial resistance
This report challenges policy-makers and political leaders to tackle fossil fuel production and consumption as a health control issue, in the same way that smoking has been reduced and regulated. Fossil fuel combustion is a major source of toxic air pollution that kills 7 million people every year,
...
Glob Health Sci Pract; March 24, 2017, Vol. 5, No. 1, pp. 44-56
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
